These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 15482646

  • 21. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 22. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B, Chai S, Li N, To KK, Kan WL, Yang D, Lin G.
    Int J Pharm; 2012 Mar 15; 424(1-2):33-9. PubMed ID: 22226881
    [Abstract] [Full Text] [Related]

  • 23. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
    Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M.
    Cancer Res; 2001 Feb 15; 61(4):1693-8. PubMed ID: 11245485
    [Abstract] [Full Text] [Related]

  • 24. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y.
    Leuk Res; 2009 Aug 15; 33(8):1114-9. PubMed ID: 19036441
    [Abstract] [Full Text] [Related]

  • 25. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J, Zhang W, Wu J, Zhu Y.
    Int J Hyperthermia; 2008 Mar 15; 24(2):151-9. PubMed ID: 18283591
    [Abstract] [Full Text] [Related]

  • 26. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 27. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
    Zheng Z, Aojula H, Clarke D.
    J Drug Target; 2010 Jul 21; 18(6):477-87. PubMed ID: 20088680
    [Abstract] [Full Text] [Related]

  • 28. Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2.
    Fu LW, He LR, Liang YJ, Chen LM, Xiong HY, Yang XP, Pan QC.
    Yao Xue Xue Bao; 2003 Aug 21; 38(8):565-70. PubMed ID: 14628443
    [Abstract] [Full Text] [Related]

  • 29. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov 21; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 30. Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity.
    Mei Y, Wei D, Liu J.
    Cancer Biol Ther; 2005 Apr 21; 4(4):468-73. PubMed ID: 15908794
    [Abstract] [Full Text] [Related]

  • 31. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q.
    Cancer Chemother Pharmacol; 2004 Apr 21; 53(4):349-56. PubMed ID: 14666379
    [Abstract] [Full Text] [Related]

  • 32. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X, Chang Z, Song J, Gao G, Shen Z.
    Anticancer Drugs; 2011 Jul 21; 22(6):556-62. PubMed ID: 21637162
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Jul 21; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D, Dekel Y, Melikhov D, Margalit R.
    Cancer Res; 2004 Oct 15; 64(20):7562-9. PubMed ID: 15492283
    [Abstract] [Full Text] [Related]

  • 37. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y, Gündüz U.
    Biomed Pharmacother; 2011 Mar 15; 65(2):85-9. PubMed ID: 21237614
    [Abstract] [Full Text] [Related]

  • 38. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro.
    Yang S, Liu J, Chen Y, Jiang J.
    Biomed Pharmacother; 2012 Apr 15; 66(3):187-94. PubMed ID: 22440896
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr 15; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 40. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R, Sasaki K, Yoshida K.
    Toxicol In Vitro; 2009 Aug 15; 23(5):834-9. PubMed ID: 19406223
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.